Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Survival benefits from follow-up of patients with lung cancer: a systematic review and meta-analysis.

Calman L, Beaver K, Hind D, Lorigan P, Roberts C, Lloyd-Jones M.

J Thorac Oncol. 2011 Dec;6(12):1993-2004. doi: 10.1097/JTO.0b013e31822b01a1. Review.

2.

Follow-up strategies for women treated for early breast cancer.

Moschetti I, Cinquini M, Lambertini M, Levaggi A, Liberati A.

Cochrane Database Syst Rev. 2016 May 27;(5):CD001768. doi: 10.1002/14651858.CD001768.pub3. Review.

PMID:
27230946
3.
4.

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Stevens R, Macbeth F, Toy E, Coles B, Lester JF.

Cochrane Database Syst Rev. 2015 Jan 14;1:CD002143. doi: 10.1002/14651858.CD002143.pub4. Review.

PMID:
25586198
5.

Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.

Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK.

Cancer Prev Control. 1997 Dec;1(5):366-78.

PMID:
9765759
6.

Follow-up strategies for patients treated for non-metastatic colorectal cancer.

Jeffery M, Hickey BE, Hider PN, See AM.

Cochrane Database Syst Rev. 2016 Nov 24;11:CD002200. Review.

PMID:
27884041
7.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

8.

Axillary treatment for operable primary breast cancer.

Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW.

Cochrane Database Syst Rev. 2017 Jan 4;1:CD004561. doi: 10.1002/14651858.CD004561.pub3. Review.

PMID:
28052186
9.

Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.

Okawara G, Rusthoven J, Newman T, Findlay B, Evans W.

Cancer Prev Control. 1997 Aug;1(3):249-59.

PMID:
9765750
10.

A randomised controlled trial to assess the cost-effectiveness of intensive versus no scheduled follow-up in patients who have undergone resection for colorectal cancer with curative intent.

Mant D, Gray A, Pugh S, Campbell H, George S, Fuller A, Shinkins B, Corkhill A, Mellor J, Dixon E, Little L, Perera-Salazar R, Primrose J.

Health Technol Assess. 2017 May;21(32):1-86. doi: 10.3310/hta21320.

11.

Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis.

Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S.

Ann Oncol. 2015 Apr;26(4):644-56. doi: 10.1093/annonc/mdu543. Epub 2014 Nov 19. Review.

PMID:
25411419
12.

Follow-up after curative resection of colorectal cancer: a meta-analysis.

Tjandra JJ, Chan MK.

Dis Colon Rectum. 2007 Nov;50(11):1783-99. Review.

PMID:
17874269
13.

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data.

NSCLC Meta-analysis Collaborative Group.

Lancet. 2014 May 3;383(9928):1561-71. doi: 10.1016/S0140-6736(13)62159-5. Epub 2014 Feb 25. Review.

14.

First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.

Greenhalgh J, Dwan K, Boland A, Bates V, Vecchio F, Dundar Y, Jain P, Green JA.

Cochrane Database Syst Rev. 2016 May 25;(5):CD010383. doi: 10.1002/14651858.CD010383.pub2. Review.

PMID:
27223332
15.

Does intensive follow-up alter outcome in patients with advanced lung cancer?

Benamore R, Shepherd FA, Leighl N, Pintilie M, Patel M, Feld R, Herman S.

J Thorac Oncol. 2007 Apr;2(4):273-81.

16.

Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.

Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Hockenhull J, Proudlove C, Dundar Y, Richardson M, Dickson R, Mullard A, Marshall E.

Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470. Review.

17.

Follow-up of patients with curatively resected colorectal cancer: a practice guideline.

Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care.

BMC Cancer. 2003 Oct 6;3:26. Review.

18.
19.

The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis.

Zhou F, Jiang T, Ma W, Gao G, Chen X, Zhou C.

Lung Cancer. 2015 Aug;89(2):203-11. doi: 10.1016/j.lungcan.2015.06.005. Epub 2015 Jun 17. Review.

PMID:
26115839
20.

Is immediate imaging important in managing low back pain?

Andersen JC.

J Athl Train. 2011 Jan-Feb;46(1):99-102. doi: 10.4085/1062-6050-46.1.99.

Supplemental Content

Support Center